No Data
No Data
No Data
No Data
No Data
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
EMERYVILLE, Calif., April 24, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, wi
PR NewswireApr 24 16:05 ET
Health Check: How Prudently Does Dynavax Technologies (NASDAQ:DVAX) Use Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we thi
Simply Wall StApr 8 06:12 ET
Dynavax Technologies Corp: Appoints Ryan Spencer to Serve as Interim Chief Financial Officer While Kelly MacDonald Is on Maternity Leave
Dynavax Technologies Corp: Appoints Ryan Spencer to Serve as Interim Chief Financial Officer While Kelly MacDonald Is on Maternity Leave
Dow JonesApr 1 16:42 ET
Dynavax (NASDAQ:DVAX) Offers Potentially Robust Growth at a Rich Valuation
TipRanksMar 19 10:09 ET
Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX)
Yahoo FinanceMar 4 23:53 ET
11 Best Small Cap Pharma Stocks to Invest In
Yahoo FinanceMar 4 20:28 ET
No Data
No Data